The Clorox Company (CLX) — Fair Value Analysis

Base-case fair value (P50): $116.07 · Current price: $105.70 · Verdict: Fairly Valued

The Verdict on CLX

Clorox (CLX) is currently Fairly Valued according to our latest Monte Carlo simulations. With a current market price of $105.70, our median fair value (P50) stands at $116.07. This indicates a potential +9.8% from the current level. While this suggests some room for appreciation, the proximity of the current price to the statistically derived P50 means CLX is neither significantly overvalued nor undervalued at this juncture. Our analysis, which runs thousands of forward scenarios, points to a balanced risk/reward profile given the present valuation.

How CLX stacks up against Consumer Defensive

Within the Consumer Defensive sector, Clorox exhibits an "average" quality tier in terms of its operational and financial health. This assessment reflects its standing relative to peers, considering various fundamental metrics that contribute to its long-term stability and growth prospects. Despite this average quality designation, the Monte Carlo simulation still derives a median fair value of $116.07, suggesting the market price of $105.70 is reasonably reflective of its intrinsic worth given sector dynamics. The indicated +9.8% implies that even an average-quality company in the Consumer Defensive space can still offer modest potential returns.

What this means for investors

For investors considering Clorox, the current analysis suggests a market price of $105.70 that closely aligns with its median fair value of $116.07. The +9.8% indicates that the market is largely pricing in its average quality tier and sector characteristics. While a "Fairly Valued" verdict doesn't preclude future price movements, it signals that significant mispricing is not evident at this time. Investors seeking more granular insights into potential bear or bull case scenarios, beyond the P50, can access the full probabilistic distribution on FairCurve. Sign up for FairCurve to see the full bear/bull distribution and track CLX's fair value as new fundamentals are released.